MedWatch

Össur driven by growth in EMEA and APAC regions in Q4

Icelandic prosthetics firm Össur, which is listed on the Copenhagen stock exchange, saw sales revenue amount to USD 718.7m in 2021, up from USD 629.5m in 2020.

Photo: Össur / PR

Össur made it out of the last quarter of 2021, and the year in its entirety, in better shape than last year.

The Icelandic prosthetics firm’s 2021 was particularly characterized by strong growth in the EMEA and APAC regions and by double-digit sales growth of the company’s prosthetics business, according to Össur’s 2021 financial report, which was released on Tuesday morning.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs